<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2695-463X</journal-id>
<journal-title><![CDATA[Revista Española de Podología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Esp Podol.]]></abbrev-journal-title>
<issn>2695-463X</issn>
<publisher>
<publisher-name><![CDATA[Inspira Network Group, S.L]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2695-463X2025000200156</article-id>
<article-id pub-id-type="doi">10.20986/revesppod.2025.1742/2025</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Implicaciones podológicas de las secuelas del síndrome de Guillain-Barré: revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Podiatric implications of guillain-barré syndrome sequelae: a systematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rayo Pérez]]></surname>
<given-names><![CDATA[Ana M.ª]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rayo Martín]]></surname>
<given-names><![CDATA[Rafae]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rayo Rosado]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García De La Peña]]></surname>
<given-names><![CDATA[Raquel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Sevilla  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>36</volume>
<numero>2</numero>
<fpage>156</fpage>
<lpage>163</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2695-463X2025000200156&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2695-463X2025000200156&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2695-463X2025000200156&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  El síndrome de Guillain-Barré es una polineuropatía inflamatoria aguda de origen autoinmune, caracterizada por debilidad muscular ascendente y compromiso sensitivo. Las secuelas funcionales en miembros inferiores permanecen insuficientemente documentadas, a pesar de su relevancia para la movilidad, el equilibrio y la calidad de vida. El objetivo es analizar y sintetizar la evidencia científica disponible sobre las implicaciones podológicas del síndrome de Guillain-Barré.  Material y métodos:  Se realizó una revisión sistemática siguiendo las directrices PRISMA 2020. Se consultaron las bases de datos PubMed, Scopus, Web of Science y PEDro, incluyendo artículos publicados hasta abril de 2025. Se seleccionaron estudios clínicos, series de casos y reportes que describieran explícitamente alteraciones o intervenciones podológicas en pacientes con síndrome de Guillain-Barré. Se aplicaron herramientas RoB 2 y ROBINS-I para la evaluación del riesgo de sesgo y se valoró la calidad metodológica de los estudios incluidos.  Resultados:  De 3186 estudios identificados, 27 cumplieron los criterios de inclusión. Las principales implicaciones podológicas encontradas fueron: pie caído, inestabilidad en tobillo, contracturas equinas, fusión articular, alteraciones en la marcha y dolor plantar persistente. Las intervenciones terapéuticas incluyeron ortesis plantares, entrenamiento con exoesqueletos, ejercicios individualizados supervisados y cirugías correctivas. El único ensayo clínico aleatorizado incluido evidenció mejoras significativas en fuerza muscular y calidad de vida mediante fisioterapia supervisada.  Conclusión:  El síndrome de Guillain-Barré genera consecuencias funcionales relevantes en la estructura y función podológica, con impacto directo en la autonomía del paciente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background:  Guillain-Barré syndrome is an acute inflammatory polyneuropathy of autoimmune origin, characterized by ascending muscle weakness and sensory impairment. The functional sequelae in the lower limbs remain insufficiently documented, despite their relevance for mobility, balance, and patient quality of life. The objective is to analyze and synthesize the available scientific evidence on the podiatric implications of Guillain-Barré syndrome.  Material and methods:  A systematic review was conducted following the PRISMA 2020 guidelines. The databases PubMed, Scopus, Web of Science, and PEDro were searched for articles published up to April 2025. Clinical studies, case series, and case reports explicitly describing podiatric alterations or interventions in patients with Guillain-Barré syndrome were included. Risk of bias was assessed using the RoB 2 and ROBINS-I tools, and the methodological quality of the included studies was evaluated.  Results:  Of the 3,186 records identified, 27 met the inclusion criteria. The main podiatric implications found were: foot drop, ankle instability, equinus contractures, joint fusion, gait disturbances, and persistent plantar pain. Therapeutic interventions included foot orthoses, exoskeleton-assisted training, supervised individualized exercise programs, and corrective surgeries. The only randomized controlled trial included reported significant improvements in muscle strength and quality of life through supervised physiotherapy.  Conclusion:  Guillain-Barré syndrome leads to relevant functional consequences in foot and ankle structure and function, with a direct impact on patient autonomy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Síndrome Gullain-Barré]]></kwd>
<kwd lng="es"><![CDATA[pie caído]]></kwd>
<kwd lng="es"><![CDATA[podología]]></kwd>
<kwd lng="es"><![CDATA[rehabilitación]]></kwd>
<kwd lng="es"><![CDATA[disfunción neuromuscular]]></kwd>
<kwd lng="es"><![CDATA[ortesis]]></kwd>
<kwd lng="es"><![CDATA[calidad de vida]]></kwd>
<kwd lng="en"><![CDATA[Guillian-Barré syndrome]]></kwd>
<kwd lng="en"><![CDATA[drop foot]]></kwd>
<kwd lng="en"><![CDATA[podiatry]]></kwd>
<kwd lng="en"><![CDATA[rehabilitation]]></kwd>
<kwd lng="en"><![CDATA[neuromuscular dysfunction]]></kwd>
<kwd lng="en"><![CDATA[orthoses]]></kwd>
<kwd lng="en"><![CDATA[quality of life]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrara]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Litchmore]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elsberg syndrome with albuminocytologic dissociation - A Guillain-Barré syndrome mimic or Guillain-Barré syndrome variant]]></article-title>
<source><![CDATA[Neurohospitalist]]></source>
<year>2024</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>322-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takemoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kawahara]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Atagi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recurrent Guillain-Barré syndrome associated with the second episode of Campylobacter jejuni Infection]]></article-title>
<source><![CDATA[Intern Med]]></source>
<year>2023</year>
<volume>62</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>3037-41</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Terán]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute meningitis followed by Campylobacter jejuni associated Guillain-Barré syndrome in a pediatric patient with COVID-19: A case report]]></article-title>
<source><![CDATA[Int J Neurosci]]></source>
<year>2025</year>
<volume>135</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>32-5</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellucci]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Germano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Grisanti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castellano]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tazza]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mobilia]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Case report: Post-COVID-19 vaccine recurrence of Guillain-Barré syndrome following an antecedent parainfectious COVID-19-related GBS]]></article-title>
<source><![CDATA[Front Immunol]]></source>
<year>2022</year>
<volume>13</volume>
<page-range>894872</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lanman]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Goyal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome with rapid onset and autonomic dysfunction following first dose of Pfizer-BioNTech COVID-19 vaccine: A case report]]></article-title>
<source><![CDATA[Neurohospitalist]]></source>
<year>2022</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>388-90</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yabuki]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshikawa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Koseki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ishibashi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Matsushita]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kohno]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improvement of functional mobility using a hip-wearable exoskeleton robot in Guillain-Barré syndrome with residual gait disturbance: A case report]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2024</year>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sidoli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bruni]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Beretta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mazzola]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bellelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: A case report]]></article-title>
<source><![CDATA[BMC Geriatr]]></source>
<year>2023</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>114</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Guedes]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonça]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome spectrum as manifestation of HIV-related immune reconstitution inflammatory syndrome: case report and literature review]]></article-title>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2022</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>102368</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ayadi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hammouga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Slim Majoul]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jamoussi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zaimi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Mensi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome in ulcerative colitis and SARS-CoV-2 infection: A case report and literature review]]></article-title>
<source><![CDATA[Future Sci OA]]></source>
<year>2024</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>FSO913</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sur]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Samasca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sur]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gaga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aldea]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome with a peculiar course: A case report]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2021</year>
<volume>13</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dukkipati]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Powers]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Piccione]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Koh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute bulbar palsy-plus variant of Guillain-Barré syndrome in a 3-year-old girl]]></article-title>
<source><![CDATA[Child Neurol Open]]></source>
<year>2022</year>
<volume>9</volume>
<page-range>2329048X221115476</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kanou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wardeh]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Govindarajan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Macnay]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barre syndrome (GBS) associated with COVID-19 infection that resolved without treatment in a child]]></article-title>
<source><![CDATA[BMJ Case Rep]]></source>
<year>2022</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yoshino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Muneuchi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Terashi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshida]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kusunoki]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Limbic encephalitis following Guillain-Barré syndrome Associated with Mycoplasma infection]]></article-title>
<source><![CDATA[Case Rep Neurol]]></source>
<year>2019</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-23</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Algahtani]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Shirah]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Abdelghaffar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Abuhawi]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Alqahtani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nitrous oxide recreational abuse presenting with myeloneuropathy and mimicking Guillain-Barre syndrome]]></article-title>
<source><![CDATA[Intractable Rare Dis Res]]></source>
<year>2020</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>54-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takeuchi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Inatomi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Nakajima]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yonehara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome with refractory optic neuropathy]]></article-title>
<source><![CDATA[Rinsho Shinkeigaku]]></source>
<year>2019</year>
<volume>59</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>652-8</page-range><publisher-loc><![CDATA[Japanese ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Shrivastava]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nagi]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervised, individualised exercise reduces fatigue and improves strength and quality of life more than unsupervised home exercise in people with chronic Guillain-Barré syndrome: A randomised trial]]></article-title>
<source><![CDATA[J Physiother]]></source>
<year>2022</year>
<volume>68</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>123-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[FY]]></given-names>
</name>
<name>
<surname><![CDATA[Hou]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
<name>
<surname><![CDATA[Siow]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Additional rehabilitative robot-assisted gait training for ambulation in geriatric individuals with Guillain-Barré syndrome: A case report]]></article-title>
<source><![CDATA[Medicina (Kaunas)]]></source>
<year>2024</year>
<volume>60</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1209</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Packiyarajah]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sundaresan]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
<name>
<surname><![CDATA[Nusair]]></surname>
<given-names><![CDATA[MSM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare sensory ataxic variant of Guillain-Barre syndrome: A case report]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2023</year>
<volume>15</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Semproni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kuyper]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tam]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unusual sensory variant of Guillain-Barré syndrome]]></article-title>
<source><![CDATA[BMJ Case Rep]]></source>
<year>2017</year>
<volume>2017</volume>
<page-range>bcr2016218935</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Successful surgical treatment of scoliosis secondary to Guillain-Barré syndrome: Case report]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2016</year>
<volume>95</volume>
<numero>26</numero>
<issue>26</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seidel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mathew]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Marks]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bilateral ankle and subtalar joint fusion secondary to Guillain Barré-induced foot drop]]></article-title>
<source><![CDATA[J Foot Ankle Surg]]></source>
<year>2016</year>
<volume>55</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>260-2</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mokhashi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Narla]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Marchionni]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barre syndrome in a patient with asymptomatic coronavirus disease 2019 infection and major depressive disorder]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2021</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[George]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Kainat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pachika]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare occurrence of Guillain-Barré syndrome after Moderna vaccine]]></article-title>
<source><![CDATA[BMJ Case Rep]]></source>
<year>2022</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wada]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kawate]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of gait training with lower limb orthosis for a patient with severe Guillain-Barré syndrome at a Kaifukuki rehabilitation ward]]></article-title>
<source><![CDATA[Jpn J Compr Rehabil Sci]]></source>
<year>2021</year>
<volume>12</volume>
<page-range>48-52</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
